Drug Discovery market research reports by DelveInsight

• Acute Hepatic Porphyria (AHP) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Hepatic Porphyria (AHP) - Pipeline Insight, 2024 Acute Hepatic Porphyria (AHP) Overview ""Acute Hepatic Porphyria (AHP) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Hepatic Porphyri ... Read More

• Vasculitis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Vasculitis - Pipeline Insight, 2024 DelveInsight’s, “Vasculitis - Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 30+ pipeline drugs in Vasculitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It al ... Read More

• Sigma Receptor Agonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Sigma Receptor Agonist - Pipeline Insight, 2024 “Sigma Receptor Agonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Sigma Receptor Agonist development. The report provides detaile ... Read More

• Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2024 “Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across ... Read More

• Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne - Pipeline Insight, 2024 Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne Overview ""Severe Acne Vulgaris or Severe Recalcitrant Nodular Acne Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present cli ... Read More

• Shigella Infections - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Shigella Infections - Pipeline Insight, 2024 Shigella Infections Overview ""Shigella Infections Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Shigella Infections market. A detailed picture of th ... Read More

• 1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2024 “1,3-Beta-Glucan Synthase Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 1,3-Beta-Glucan Synthase Inhibitor deve ... Read More

• Female Trichomoniasis Vaginalis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Female Trichomoniasis Vaginalis - Pipeline Insight, 2024 Female Trichomoniasis Vaginalis Overview ""Female Trichomoniasis Vaginalis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Female Trichomon ... Read More

• Glaucoma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Glaucoma - Pipeline Insight, 2024 DelveInsight’s, “Glaucoma Disease- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Glaucoma Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage prod ... Read More

• Turner Syndrome - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Turner Syndrome - Pipeline Insight, 2024 DelveInsight’s, “Turner Syndrome - Pipeline Insight, 2024” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Turner Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pr ... Read More

• Type 1 fibroblast growth factor receptor antagonists - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Type 1 fibroblast growth factor receptor antagonists - Pipeline Insight, 2024 DelveInsight’s, “Type 1 Fibroblast Growth Factor Receptor Antagonists - Pipeline Insight, 2024” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Type 1 Fibroblast Growth Factor Receptor ... Read More

• Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2024 Athlete's Foot (Tinea Pedis) Overview ""Athlete's Foot (Tinea Pedis) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Athlete's Foot (Tinea Ped ... Read More

• ATPase Inhibitor - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  ATPase Inhibitor - Pipeline Insight, 2024 “ATPase Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across ATPase Inhibitor development. The report provides detailed coverage of the ... Read More

• Atrial Flutter - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Atrial Flutter - Pipeline Insight, 2024 Atrial Flutter Overview ""Atrial Flutter Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Atrial Flutter market. A detailed picture of the Atrial Flutter pip ... Read More

• Autism - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Autism - Pipeline Insight, 2024 Autism Overview ""Autism Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Autism market. A detailed picture of the Autism pipeline landscape is provided, which inclu ... Read More

• Chlamydia Infections - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Chlamydia Infections - Pipeline Insight, 2024 DelveInsight’s, “Chlamydia Infections - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Chlamydia Infections pipeline landscape. It covers the pipeline drug profiles, including clinical and nonc ... Read More

• Chondrosarcoma- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Chondrosarcoma- Pipeline Insight, 2024 DelveInsight’s, “Chondrosarcoma- Pipeline Insight, 2024” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in Chondrosarcoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage produ ... Read More

• Chronic Heart Failure- Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Chronic Heart Failure- Pipeline Insight, 2024 DelveInsight’s, “Chronic Heart Failure- Pipeline Insight, 2024” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Chronic Heart Failure pipeline landscape. It covers the pipeline drug profiles, including clinical and no ... Read More

• Chronic Kidney Disease - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Chronic Kidney Disease - Pipeline Insight, 2024 DelveInsight’s, “Chronic Kidney Disease - Pipeline Insight, 2024” report provides comprehensive insights about 76+ companies and 80+ pipeline drugs in Chronic Kidney Disease pipeline landscape. It covers the pipeline drug profiles, including clinical a ... Read More

• Molybdenum Cofactor Deficiency Type-A (MoCoD-A) - Market Insights, Epidemiology, and Market Forecast–2034

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Molybdenum Cofactor Deficiency Type-A (MoCoD-A) - Market Insights, Epidemiology, and Market Forecast–2034 Key Highlights: Menkes disease diagnosed prevalence is expected to rise, driven by advancements in genetic testing, increased awareness, improved survival rates, genetic factors, expanded screen ... Read More

• Adenosine A2B Receptor Antagonist - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Adenosine A2B Receptor Antagonist - Pipeline Insight, 2024 “Adenosine A2B Receptor Antagonist - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A2B Receptor Antagonist develop ... Read More

• Adrenal Crisis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Adrenal Crisis - Pipeline Insight, 2024 Adrenal Crisis Overview ""Adrenal Crisis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Adrenal Crisis market. A detailed picture of the Adrenal Crisis pip ... Read More

• Adrenal Insufficiency - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Adrenal Insufficiency - Pipeline Insight, 2024 Adrenal Insufficiency Overview ""Adrenal Insufficiency Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Adrenal Insufficiency market. A detailed pictu ... Read More

• Adult R/R RAF-Altered Solid Tumors - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Adult R/R RAF-Altered Solid Tumors - Pipeline Insight, 2024 Adult R/R RAF-Altered Solid Tumors Overview ""Adult R/R RAF-Altered Solid Tumors Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Adult R ... Read More

• African Trypanosomiasis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  African Trypanosomiasis - Pipeline Insight, 2024 African Trypanosomiasis Overview ""African Trypanosomiasis Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the African Trypanosomiasis market. A detail ... Read More

< prev 42 43 44 45 46 47 48 49 50 next >